Galectin Therapeutics Inc. (GALT) vs Utah Medical Products, Inc. (UTMD)

A side-by-side comparison of Galectin Therapeutics Inc. and Utah Medical Products, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GALT vs UTMD

growth of $100 · dividends reinvested · last 10y
GALT +166.4% (+10.3%/yr)UTMD +41.1% (+3.5%/yr)GALT compounded faster over this window
200400600Start $10020182020202220242026$266$141
GALT UTMD

GALT vs UTMD: by the numbers

  • •GALT is the larger company ($248M vs $235M market cap).
  • •UTMD is profitable (29.04% net margin) while GALT runs a net loss (0.00%).
  • •UTMD pays a dividend (1.67% yield), while GALT has no payments in the available dividend history.

Metrics side by side

Valuation

MetricGALTUTMD
P/E ratioN/A22.51
PEG ratioN/A6.56
P/S ratioN/A6.51
P/B ratioN/A1.93
EV / EBITDAN/A18.54
FCF yieldN/A4.87%

Profitability

MetricGALTUTMD
Gross margin0.00%54.88%
Operating margin0.00%28.46%
Net margin0.00%29.04%
ROEN/A8.59%
ROIC-1718.59%6.83%

Dividends

MetricGALTUTMD
Dividend yieldN/A1.67%
Payout ratioN/A37.80%

Growth (annualized)

MetricGALTUTMD
Revenue CAGR (5Y)N/A-4.75%
EPS CAGR (5Y)N/A3.36%
FCF CAGR (5Y)N/A-11.12%
Total return CAGR (5Y)0.60%-2.70%

Frequently asked

Does GALT or UTMD pay a bigger dividend?
UTMD pays a dividend (1.67% yield), while GALT has no payments in the available dividend history.
Is GALT or UTMD more profitable?
UTMD runs the higher net margin — GALT at 0.00% versus UTMD at 29.04%.
How have GALT and UTMD total returns compared?
Over the past 10 years, GALT delivered 13.41% and UTMD delivered 3.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.